Electrochemical DNA Biosensor That Detects Early Celiac Disease Autoantibodies

Area of Science:

• Biomedical Engineering
• Immunology
• Diagnostic Technology

Background:

• Celiac disease (CD) affects over one million Americans, yet diagnosis remains challenging due to overlapping symptoms and the need for invasive procedures.
• Current gold standard diagnostics involve serological tests and confirmatory biopsies, highlighting the need for less invasive alternatives.
• Autoimmune and inflammatory responses to gluten ingestion characterize CD, necessitating improved detection methods.

Purpose of the Study:

• To develop and assess a novel electrochemical DNA (E-DNA) biosensor for detecting celiac disease-specific autoantibodies (AABs).
• To provide a less invasive diagnostic tool for celiac disease compared to traditional methods.
• To evaluate the biosensor's sensitivity, specificity, and dose-dependent detection capabilities.

Main Methods:

• An electrochemical DNA (E-DNA) biosensor was designed to detect CD-specific AABs by measuring current reduction upon antibody binding to a synthetic neoepitope.
• The biosensor's performance was evaluated using patient-derived AABs in physiological buffer and supplemented bovine serum.
• Detection was assessed for dose-dependency and specificity against unrelated biomarkers.

Main Results:

• The E-DNA biosensor successfully detected CD-specific AABs in a dose-dependent manner, with an apparent dissociation constant of 0.09 ± 0.03 units/mL.
• The biosensor demonstrated high target specificity, showing minimal off-target binding with other biomarkers.
• A measurable current reduction correlated directly with the concentration of AABs present.

Conclusions:

• The developed E-DNA biosensor presents a promising, less invasive method for detecting celiac disease-specific autoantibodies.
• This biosensor technology has the potential to significantly improve diagnostic tools for celiac disease.
• Further research focusing on enhancing sensitivity in complex biological media could advance CD diagnostic capabilities.